| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |